That's another angle GF - and it makes sense. The beauty of Novogen is that all the preliminary hard work has been done (as far as I can imagine anyway) and the chances of failure in the short term at least have been minimalized.
So not a lot of downside in 2016 and if the results start to look spectacular he gets to ride that. He might be betting that could fast track him to a higher position than before into a big pharma.
You could be right.
- Forums
- ASX - By Stock
- Ann: Novogen Appoints Dr James Garner as New CEO
That's another angle GF - and it makes sense. The beauty of...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)